Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Fc fragment of IgG receptor IIb | 0.522 | 0.846 | 0.46 |
|
disease | 0.900 | None | 0.980 | 8 | 0 | 1995 | 2019 | ||||||||
|
deoxyribonuclease 1 | 0.505 | 0.846 | 7.0E-21 |
|
disease | 0.900 | None | 0.955 | 1 | 0 | 2000 | 2020 | ||||||||
|
programmed cell death 1 | 0.402 | 0.846 | 0.42 |
|
disease | 0.800 | None | 0.949 | 7 | 0 | 1998 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.800 | None | 0.952 | 3 | 0 | 2004 | 2019 | ||||||||
|
three prime repair exonuclease 1 | 0.517 | 0.808 | 0.58 |
|
disease | 0.800 | strong | 0.967 | 2 | 0 | 2007 | 2020 | ||||||||
|
interferon regulatory factor 5 | 0.489 | 0.731 | 9.0E-03 |
|
disease | 0.700 | None | 0.949 | 11 | 0 | 2005 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.700 | None | 0.945 | 8 | 0 | 1994 | 2019 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.700 | None | 0.829 | 6 | 0 | 1998 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.700 | None | 0.882 | 5 | 0 | 1990 | 2019 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.700 | None | 0.961 | 4 | 0 | 2002 | 2020 | ||||||||
|
complement C4A (Rodgers blood group) | 0.563 | 0.769 | 1.5E-11 |
|
disease | 0.700 | None | 0.957 | 3 | 0 | 1987 | 2018 | ||||||||
|
TNF alpha induced protein 3 | 0.481 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.929 | 1 | 0 | 2008 | 2019 | ||||||||
|
B cell scaffold protein with ankyrin repeats 1 | 0.653 | 0.538 | 4.8E-12 |
|
disease | 0.700 | None | 0.955 | 1 | 0 | 2008 | 2019 | ||||||||
|
integrin subunit alpha M | 0.443 | 0.808 | 3.3E-11 |
|
disease | 0.700 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
complement C3d receptor 2 | 0.556 | 0.654 | 4.7E-19 |
|
disease | 0.690 | moderate | 1.000 | 1 | 0 | 2006 | 2020 | ||||||||
|
PX domain containing serine/threonine kinase like | 0.821 | 0.231 | 1.1E-02 |
|
disease | 0.670 | None | 0.875 | 1 | 0 | 2008 | 2015 | ||||||||
|
complement C4B (Chido blood group) | 0.603 | 0.808 | 0.83 |
|
disease | 0.600 | None | 0.944 | 2 | 0 | 1985 | 2019 | ||||||||
|
Fc fragment of IgG receptor IIa | 0.480 | 0.769 | 2.0E-06 |
|
disease | 0.500 | None | 0.906 | 3 | 0 | 1995 | 2019 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.500 | None | 0.952 | 1 | 0 | 1998 | 2019 | ||||||||
|
interleukin 1 receptor associated kinase 1 | 0.506 | 0.808 | 0.99 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
PHD and ring finger domains 1 | 0.743 | 0.346 | 5.7E-02 |
|
disease | 0.470 | None | 0.875 | 1 | 0 | 2008 | 2012 | ||||||||
|
Fc fragment of IgG receptor IIIb | 0.452 | 0.962 | 3.0E-07 |
|
disease | 0.400 | None | 0.925 | 4 | 0 | 1999 | 2019 | ||||||||
|
prolactin | 0.406 | 0.885 | 2.9E-07 |
|
disease | 0.400 | None | 0.963 | 4 | 0 | 1997 | 2019 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.400 | None | 0.943 | 3 | 0 | 1978 | 2020 |